The Center for Medicare and Medicaid Innovation (CMMI) officially announced the Cell and Gene Therapy (CGT) Access Model, with sickle cell disease as the initial focus of the model (fact sheet, FAQs) The model is pursuant to President Biden’s executive order entitled “Lowering Prescription Drug Costs for Americans and, subsequently, CMMI’s February 2023 report detailing three potential models to be… (Slifer, January 30, 2024) #Demonstration Programs, #Drug Pricing, #Prescription Drugs